Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes
Zhangru Yang, Ning Zhao, Jin Meng, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 26422-26435
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Assessing the interactions between radiotherapy and antitumour immunity
Clemens Grassberger, Susannah G. Ellsworth, Moses Q. Wilks, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 12, pp. 729-745
Closed Access | Times Cited: 207
Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
Susannah G. Ellsworth
Advances in Radiation Oncology (2018) Vol. 3, Iss. 4, pp. 512-519
Open Access | Times Cited: 145
A review on lymphocyte radiosensitivity and its impact on radiotherapy
Harald Paganetti
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 40
Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
Jing Liu, Qianqian Zhao, Weiye Deng, et al.
Radiation Oncology (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis
Qin Wang, Shangbiao Li, Simiao Qiao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
Impact of curative radiotherapy on the immune status of patients with localized prostate cancer
Franziska Eckert, Philipp Schaedle, Daniel Zips, et al.
OncoImmunology (2018) Vol. 7, Iss. 11
Open Access | Times Cited: 40
Peripheral blood lymphocyte subsets are associated with the clinical outcomes of prostate cancer patients
Fei Mao, Chao Yang, Weiyu Luo, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109287-109287
Closed Access | Times Cited: 21
The current understanding of the immune landscape relative to radiotherapy across tumor types
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients
Chunling Yuan, Q. Wang
Clinical & Translational Oncology (2018) Vol. 20, Iss. 9, pp. 1219-1225
Closed Access | Times Cited: 33
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer
Maddalena Pavarini, Lisa Alborghetti, Stefania Aimonetto, et al.
Radiotherapy and Oncology (2024) Vol. 195, pp. 110230-110230
Closed Access | Times Cited: 3
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer
Akinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, et al.
Gastric Cancer (2020) Vol. 23, Iss. 5, pp. 893-903
Open Access | Times Cited: 27
Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer
Chao Liu, Qinyong Hu, Kai Hu, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 26
Hadrontherapy Interactions in Molecular and Cellular Biology
Juliette Thariat, Samuel Valable, Carine Laurent, et al.
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 133-133
Open Access | Times Cited: 25
Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells – Implications for systemic control
Hanzhi Wang, Lucas C. Mendez, Gerard Morton, et al.
Radiotherapy and Oncology (2024) Vol. 191, pp. 110077-110077
Open Access | Times Cited: 2
A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regression
Jiayi Chen, Yu Feng, Ganyuan He, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Brazilian berry extract (Myrciaria jaboticaba): A promising therapy to minimize prostatic inflammation and oxidative stress
Celina Almeida Lamas, Larissa Akemi Kido, Túlio de Almeida Hermes, et al.
The Prostate (2020) Vol. 80, Iss. 11, pp. 859-871
Closed Access | Times Cited: 18
The Systemic Inflammation Score is Associated with the Survival of Patients with Prostate Cancer
Jie Xie, Xiao Xu, Zhenjia Dong, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 963-975
Open Access | Times Cited: 6
T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation
Michael Cerqueira, Karen L. Ferrari, Amílcar Castro de Mattos, et al.
World Journal of Urology (2019) Vol. 38, Iss. 3, pp. 673-680
Closed Access | Times Cited: 17
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
Giuseppe Sanguineti, Diana Giannarelli, Maria Grazia Petrongari, et al.
Radiation Oncology (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 12
The Correlation Between Low-Dose Radiotherapy Area of the Mediastinum and CD8+T Cells and the Efficacy of Radiotherapy for Non-Small Cell Lung Cancer
Hang Wang, Yang Li, Pingping Hu, et al.
Cancer Management and Research (2024) Vol. Volume 16, pp. 23-35
Open Access | Times Cited: 1
Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer
Wei Hu, Yulei Pei, Renli Ning, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 8, pp. 4533-4545
Open Access | Times Cited: 7
Landscape of Carbon Ion Radiotherapy in Prostate Cancer: Clinical Application and Translational Research
Xue Chen, Qi Yu, Ping Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment
Fiorella D′Auria, Teodora Statuto, Luciana Rago, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
Paulius Bosas, Gintaras Zaleskis, Daiva Dabkevičienė, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3709-3709
Open Access | Times Cited: 6
Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: A systematic review of the literature
Willeke Danckaert, Mathieu Spaas, Katrien Vandecasteele, et al.
Radiotherapy and Oncology (2022) Vol. 170, pp. 64-69
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top